Boston, MA -- (SBWIRE) -- 11/03/2016 -- Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016" provides an overview of Injectable Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Injectable Drug Delivery pipeline products.

Get More Details on this Report and a Full Table of Contents at Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

-Extensive coverage of the Injectable Drug Delivery under development

-The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

-The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects

-The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

-The report provides key clinical trial data of ongoing trials specific to pipeline products

-Recent developments in the segment / industry

Reasons to Get This Report

The report enables you to -

-Formulate significant competitor information, analysis, and insights to improve R&D strategies

-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

-Identify and understand important and diverse types of Injectable Drug Delivery under development

-Develop market-entry and market expansion strategies

-Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

-In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned in this Report: Aciont Inc., Actavis Inc., AdrenaCard, Inc., Allergan, Inc., Alsensa ApS, AMAG Pharmaceuticals, Inc., Amgen Inc., Antares Pharma, Inc., Anterion Therapeutics, Inc., Arnali, LLC, Artemes Technologies, Inc., AstraZeneca Plc, Atanse, Inc., AzureBio, S.L., Becton, Dickinson and Company, Bespak Europe Ltd., Biodel Inc., BioMarin Pharmaceutical Inc., BioRestorative Therapies, Inc., Boston University, BTG Plc, Burke Pharmaceuticals, LLC, Callisyn Biomedical Inc, Cambridge Consultants Limited, Case Western Reserve University, Cincinnati Children's Hospital Medical Center, Clearside BioMedical, Inc., Consort Medical plc, Credence MedSystems, Inc., CrossCoat Medical LLC, Cytosial Biomedic, S.a.s., DALI Medical Devices Ltd., Delcath Systems, Inc., DelSite, Inc., Elcam Medical, EmboMedics, Emergent BioSolutions Inc., Eveon SAS, Ghent University, Hannover Medical School, Indian Institute of Science, Inovio Pharmaceuticals, Inc., LyoGo, Medicom Innovation Partner a/s, Meridian Medical Technologies, Inc., Mertiva AB, Microchips Biotech, Inc., Midatech Pharma Plc, Milestone Scientific Inc., North Carolina State University, Ocelus, Oval Medical Technologies Limited, Particle Therapeutics Ltd, Pfizer Inc., Portal Instruments, Inc., pSivida Corp., Ratio, Inc., Recon Therapeutics, LLC, Replenish Inc, RepliCel Life Sciences, Inc., RetinaPharma Technologies, Inc., Rx Safes, Inc., Scandinavian Health Ltd, Shire Plc, Spine Smith, LP, Sun Pharmaceutical Industries Limited, TCB medical devices, Teva Pharmaceutical Industries Ltd., Texas Tech University, TheraKine Ltd., Unilife Corporation, United Therapeutics Corporation, University College London, University of Auckland, University of Calgary, University of California, Irvine, University of California, San Diego, University of California, San Francisco, University of Delaware, University of Dundee, University of Florida, University of Missouri, University of Saskatchewan, University of Texas at Austin, Urodelia SA, Vanderbilt University

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

-Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016
-Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Medical Devices Pipeline Assessment, 2016
-Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2016
-Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016
-Infusion Systems - Medical Devices Pipeline Assessment, 2015